Human angiotensinogen +11525 C/A polymorphism modulates its gene expression through microRNA binding

Physiological Genomics

Volumn 45, Issue 19, 2013, Pages 901-906

  Mopidevi, Brahmaraju ^a   Ponnala, Madhusudhan ^a   Kumar, Ashok ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

3 untranslated region; Blood pressure regulation; Human angiotensinogen gene; Hypertension; miRNA; Rs7079; Single nucleotide polymorphism

Indexed keywords

ANGIOTENSINOGEN; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 31; MICRORNA 584; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERTENSION; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING;

3′-UNTRANSLATED REGION; BLOOD PRESSURE REGULATION; HUMAN ANGIOTENSINOGEN GENE; HYPERTENSION; MIRNA; RS7079; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANGIOTENSINOGEN; BASE SEQUENCE; BINDING SITES; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RNA, MESSENGER;

EID: 84884944405     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00056.2013     Document Type: Article

References (28)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
2. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009.
3. Corvol P, Soubrier F, Jeunemaitre X. Molecular genetics of the reninangiotensin-aldosterone system in human hypertension. Pathol Biol (Paris) 45: 229-239, 1997.
4. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995-1003, 2002.
5. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899, 2008.
6. Elmen J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, Hedtjarn M, Hansen JB, Hansen HF, Straarup EM, McCullagh K, Kearney P, Kauppinen S. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36: 1153-1162, 2008.
7. Galis ZS, Thrasher T, Reid DM, Stanley DV, Oh YS. Investing in high blood pressure research: a national institutes of health perspective. Hypertension 61: 757-761, 2013.
8. Glasser SP, Judd S, Basile J, Lackland D, Halanych J, Cushman M, Prineas R, Howard V, Howard G. Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Hypertens 24: 194-199, 2011.
9. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5: 86-89, 1971.
10. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 87: 1816-1828, 1993.
11. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 25: 688-693, 1995.
12. Jain S, Tillinger A, Mopidevi B, Pandey VG, Chauhan CK, Fiering SN, Warming S, Kumar A. Transgenic mice with-6A haplotype of the human angiotensinogen gene have increased blood pressure compared with-6G haplotype. J Biol Chem 285: 41172-41186, 2010.
13. Jain S, Vinukonda G, Fiering SN, Kumar A. A haplotype of human angiotensinogen gene containing-217A increases blood pressure in transgenic mice compared with-217G. Am J Physiol Regul Integr Comp Physiol 295: R1849-R1857, 2008.
14. Kretowski A, McFann K, Hokanson JE, Maahs D, Kinney G, Snell-Bergeon JK, Wadwa RP, Eckel RH, Ogden L, Garg S, Li J, Cheng S, Erlich HA, Rewers M. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes 56: 863-871, 2007.
15. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689, 2005.
16. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
17. Lee Y, Han J, Yeom KH, Jin H, Kim VN. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol 71: 51-57, 2006.
18. Lee Y, Kim M, Han J, Yeom KH, LEES, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060, 2004.
19. Luft FC. Molecular genetics of human hypertension. J Hypertens 16: 1871-1878, 1998.
20. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 356: 1955-1964, 2000.
21. Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Gupta M, Javed S, Pasha MQ. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. J Hypertens 26: 1094-1101, 2008.
22. Nickenig G, Ostergren J, Struijker-Boudier H. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers. J Renin Angiotensin Aldosterone Syst 7, Suppl 1: S1-S7, 2006.
23. Ono M, Ochi T, Munekage K, Ogasawara M, Hirose A, Nozaki Y, Takahashi M, Okamoto N, Saibara T. Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis. Hepatol Res 41: 1223-1229, 2011.
24. Putta S, Lanting L, Sun G, Lawson G, Kato M, Natarajan R. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 23: 458-469, 2012.
25. Rasmussen-Torvik LJ, North KE, Gu CC, Lewis CE, Wilk JB, Chakravarti A, Chang YP, Miller MB, Li N, Devereux RB, Arnett DK. A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes. Hypertension 46: 1294-1299, 2005.
26. Schmidt H, Aulchenko YS, Schweighofer N, Schmidt R, Frank S, Kostner GM, Ott E, van Duijn C. Angiotensinogen promoter B-haplotype associated with cerebral small vessel disease enhances basal transcriptional activity. Stroke 35: 2592-2597, 2004.
27. Schmidt H, Fazekas F, Kostner GM, van Duijn CM, Schmidt R. Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke 32: 405-412, 2001.
28. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet 24: 489-497, 2008.